1/7
07:11 am
lrmr
Larimar Therapeutics (NASDAQ:LRMR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
Larimar Therapeutics (NASDAQ:LRMR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
12/18
08:00 am
lrmr
Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference